BARCLAYS PLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$741
-11.6%
136,021
+8.9%
0.00%
-100.0%
Q2 2023$838
-53.1%
124,909
-38.3%
0.00%0.0%
Q1 2023$1,786
-60.9%
202,429
-66.2%
0.00%
-50.0%
Q4 2022$4,572
-99.6%
598,564
+276.8%
0.00%
+100.0%
Q3 2022$1,131,000
+89.8%
158,838
+115.5%
0.00%
Q2 2022$596,000
+11.6%
73,719
+91.8%
0.00%
Q1 2022$534,000
-97.2%
38,443
-94.3%
0.00%
-100.0%
Q4 2021$18,846,000
+1299.1%
671,616
+1593.0%
0.00%
+300.0%
Q3 2021$1,347,000
+42.2%
39,671
+71.2%
0.00%
Q2 2021$947,000
-66.0%
23,172
-66.5%
0.00%
-100.0%
Q1 2021$2,782,000
-53.8%
69,090
-32.2%
0.00%
-66.7%
Q4 2020$6,028,000
+150600.0%
101,940
+115740.9%
0.00%
Q3 2020$4,000
-99.6%
88
-99.6%
0.00%
-100.0%
Q2 2020$1,135,000
+2001.9%
23,469
+1116.6%
0.00%
Q1 2020$54,000
+500.0%
1,929
+530.4%
0.00%
Q4 2019$9,000
-95.3%
306
-95.1%
0.00%
Q3 2019$191,000
-72.4%
6,206
-56.7%
0.00%
Q2 2019$693,00014,3310.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders